Literature DB >> 3407548

Local anti-inflammatory activities of tixocortol 21-pivalate, inhibition of prostaglandins and leukotrienes synthesis, in carrageenin-induced pleurisy. Reversion of effects by RU 486.

V Lelievre1, B Martin, J L Junien, J Bure.   

Abstract

Since a direct effect of tixocortol pivalate (TP) has been described on cyclooxygenase pathway, local anti-inflammatory activities of some 21 thiol derivatives of steroids were investigated on the carrageenin-induced pleurisy model in comparison with dexamethasone (Dex) or other anti-inflammatory drugs. LTC4/D4 contents in pleural fluid were assayed by RIA as well as PGE2 levels to characterize the effects on arachidonate pathways. After oral administration, TP was inactive up to 1 g/kg on exudate volume and leukocyte migration as expected for this strict local anti-inflammatory steroid contrary to Dex (ID50 = 0.05-0.41 mg/kg). When administered locally, TP and tixocortol (T) exerted a dose dependent inhibitory activity on exudate volume (ID30 = 12.4 micrograms or 13.1 micrograms/pleural cavity) and leukocyte count (ID30 = 83 or 230 micrograms); in the same conditions. Dex was more active (ID30 = 0.7 and 2.6 micrograms). All these steroids decreased PGE2 and LTC4/D4 contents in exudate fluids, respectively TP (50 micrograms/pleural cavity) by 28 and 63%; T (100 micrograms) by 33 and 31%; Dex (5 micrograms) by 43 and 40%. Local co-administration of RU 486 (50 micrograms) with either TP, T or Dex reversed the anti-inflammatory effects of all steroids, indicating in these conditions a local activity through glucosteroid receptor occupancy.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3407548     DOI: 10.1007/bf01968097

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  16 in total

1.  Distribution of prostaglandins in inflammatory exudate.

Authors:  G P Velo; C J Dunn; J P Giroud; J Timsit; D A Willoughby
Journal:  J Pathol       Date:  1973-11       Impact factor: 7.996

2.  Tixocortol pivalate and beclomethasone dipropionate in seasonal allergic rhinitis: a double-blind study.

Authors:  P Gumowski; C de Gournay; J P Girard
Journal:  J Int Med Res       Date:  1985       Impact factor: 1.671

3.  A comparison of the acute inflammatory response in adrenalectomised and sham-operated rats.

Authors:  R J Flower; L Parente; P Persico; J A Salmon
Journal:  Br J Pharmacol       Date:  1986-01       Impact factor: 8.739

4.  Radioimmunoassay of prostaglandins Falpha, E1 and E2 in human plasma.

Authors:  F Dray; B Charbonnel; J Maclouf
Journal:  Eur J Clin Invest       Date:  1975-07-29       Impact factor: 4.686

5.  Effects of several anti-inflammatory drugs on the various parameters involved in the inflammatory response in rat carrageenin-induced pleurisy.

Authors:  T Mikami; K Miyasaka
Journal:  Eur J Pharmacol       Date:  1983-11-11       Impact factor: 4.432

6.  Direct inhibition of cyclooxygenase pathway in platelets by tixocortol 21-pivalate: comparison with related structures, steroidal and non steroidal anti-inflammatory drugs.

Authors:  V Lelievre; B Martin; J Bure; J L Junien
Journal:  Agents Actions       Date:  1988-06

7.  Inhibition of human basophil leukotriene release by antiinflammatory steroids.

Authors:  R P Schleimer; D A Davidson; S P Peters; L M Lichtenstein
Journal:  Int Arch Allergy Appl Immunol       Date:  1985

8.  Detection of leukotriene C4 and D4 in the exudate of rat carrageenin-induced pleurisy.

Authors:  A Ueno; K Tanaka; M Katori
Journal:  Prostaglandins       Date:  1983-09

9.  Pharmacological study of a new anti-inflammatory steroid, tixocortol pivalate (JO 1016).

Authors:  J E Davies; D N Kellet; M W Staniforth; R Torossian; A Grouhel
Journal:  Arzneimittelforschung       Date:  1981

10.  Tixocortol pivalate, a corticosteroid with no systemic glucocorticoid effect after oral, intrarectal, and intranasal application.

Authors:  P Larochelle; P Du Souich; E Bolte; J Lelorier; R Goyer
Journal:  Clin Pharmacol Ther       Date:  1983-03       Impact factor: 6.875

View more
  2 in total

1.  Sparfloxacin, ethambutol, and cortisol receptor inhibitor RU-40 555 treatment for disseminated Mycobacterium avium complex infection of normal C57BL/6 mice.

Authors:  C Perronne; Y Cohen; C Truffot-Pernot; J Grosset; J L Vildé; J J Pocidalo
Journal:  Antimicrob Agents Chemother       Date:  1992-11       Impact factor: 5.191

2.  Direct inhibition of cyclooxygenase pathway in platelets by tixocortol 21-pivalate: comparison with related structures, steroidal and non steroidal anti-inflammatory drugs.

Authors:  V Lelievre; B Martin; J Bure; J L Junien
Journal:  Agents Actions       Date:  1988-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.